A
Acticor Biotech SA
PAR:ALACT
Acticor Biotech SA
PAR:ALACT
Price:
0.25
EUR
Market Closed
Market Cap:
€3.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Acticor Biotech SA
PAR:ALACT
|
FR |
|
H
|
Human Creation Holdings Inc
TSE:7361
|
JP |
|
NARI Technology Co Ltd
SSE:600406
|
CN |
|
M
|
Monitor Ventures Inc
XTSX:MVI.H
|
CA |
|
Steel & Tube Holdings Ltd
NZX:STU
|
NZ |
|
Indo Kordsa Tbk PT
IDX:BRAM
|
ID |
|
Cincinnati Financial Corp
NASDAQ:CINF
|
US |
|
Sherwin-Williams Co
NYSE:SHW
|
US |
|
C
|
Capital Partners SA
WSE:CPA
|
PL |
|
N
|
NewGLab Pharma Co Ltd
KOSDAQ:214870
|
KR |
|
T
|
TechL Co Ltd
KOSDAQ:064520
|
KR |
|
C
|
CICT Mobile Communication Technology Co Ltd
SSE:688387
|
CN |
|
Nihon Nohyaku Co Ltd
TSE:4997
|
JP |
|
KB Financial Group Inc
KRX:105560
|
KR |
|
Addex Therapeutics Ltd
NASDAQ:ADXN
|
CH |
|
Ador Multi Products Ltd
BSE:523120
|
IN |
|
Burcon NutraScience Corp
TSX:BU
|
CA |
|
C
|
China Jo-Jo Drugstores Holdings Inc
NASDAQ:CJJD
|
CN |
|
Sharp Corp
TSE:6753
|
JP |
|
H
|
Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267
|
CN |
|
Next Science Ltd
ASX:NXS
|
AU |
|
MTR Corp Ltd
HKEX:66
|
HK |
|
S
|
Spiritus Mundi PLC
LSE:SPMU
|
UK |
|
Ecosuntek SpA
MIL:ECK
|
IT |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of ALACT.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ALACT
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
ALACT Competitors Multiples
Acticor Biotech SA Competitors
Acticor Biotech SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
A
|
Acticor Biotech SA
PAR:ALACT
|
3.9m EUR | 0 | -0.2 | -0.2 | -0.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD | 6.1 | 88.4 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 109.4 | -1 708.3 | 15 870 | -1 791.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD | 5.7 | 19.6 | 12.3 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD | 9.2 | 27.8 | 20.9 | 21.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD | 3.2 | 35.1 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
